SCHEDULE: CVI Investments and Heights Capital Management Disclose 9.9% Stake in Nano Labs Ltd
Beneficial Ownership Disclosure
CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., have disclosed a beneficial ownership of 9.9% of Nano Labs Ltd's Class A Ordinary Shares.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, the "Reporting Persons") have filed a Schedule 13G, reporting beneficial ownership of 2,110,200 Class A Ordinary Shares of Nano Labs Ltd.
- This aggregate amount represents 9.9% of Nano Labs Ltd's Class A Ordinary Shares outstanding.
- The reported beneficial ownership includes 1,700,000 Class A Ordinary Shares and additional shares issuable upon the exercise of warrants.
- The warrants are subject to a limitation, preventing their exercise if the total beneficial ownership by a Reporting Person and its affiliates would exceed 9.99%.
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and holds shared voting and dispositive power over the reported shares.
- As of the completion of the offering referenced in the Prospectus Supplement filed on June 27, 2025, Nano Labs Ltd had 20,712,924 Class A Ordinary Shares outstanding, excluding shares underlying the warrants.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, providing no explicit positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- The disclosure of a significant 9.9% stake by institutional investors like CVI Investments, Inc. and Heights Capital Management, Inc. can be interpreted as a vote of confidence in Nano Labs Ltd's future prospects.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership by institutional investors and does not contain any forward-looking statements or guidance from Nano Labs Ltd's management regarding the company's future performance or strategic direction.
Industry Context
This filing represents a standard disclosure of significant institutional investment in a publicly traded company, common within the financial industry. It indicates that CVI Investments, Inc., managed by Heights Capital Management, Inc., has taken a substantial equity position in Nano Labs Ltd, a routine event in capital markets for transparency and regulatory compliance.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake provides transparency regarding the ownership structure and may influence investor perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2015-07-16 | Date of the Limited Power of Attorney granted by CVI Investments, Inc. to Heights Capital Management, Inc., and the Discretionary Investment Management Agreement. |
| 2023-08-14 | Date of Nano Labs Ltd's Prospectus (Registration No. 333-273968). |
| 2025-06-26 | Date of the event which required the filing of this Schedule 13G statement. |
| 2025-06-27 | Date of Nano Labs Ltd's Prospectus Supplement filing. |
| 2025-07-01 | Date of signature for the Schedule 13G filing and the Joint Filing Agreement by the Reporting Persons. |
Keywords
Nano Labs Ltd, CVI Investments, Heights Capital Management, Schedule 13G, beneficial ownership, Class A Ordinary Shares, institutional investment, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.